PL2170359T3 - Zastosowanie otoczek drożdży do leczenia i/lub zapobiegania hiperinsulinemii - Google Patents
Zastosowanie otoczek drożdży do leczenia i/lub zapobiegania hiperinsulinemiiInfo
- Publication number
- PL2170359T3 PL2170359T3 PL08786472.4T PL08786472T PL2170359T3 PL 2170359 T3 PL2170359 T3 PL 2170359T3 PL 08786472 T PL08786472 T PL 08786472T PL 2170359 T3 PL2170359 T3 PL 2170359T3
- Authority
- PL
- Poland
- Prior art keywords
- treating
- preventing hyperinsulinemia
- yeast flakes
- flakes
- yeast
- Prior art date
Links
- 206010060378 Hyperinsulinaemia Diseases 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 title 1
- 201000008980 hyperinsulinism Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0756731A FR2919187B1 (fr) | 2007-07-25 | 2007-07-25 | Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2170359T3 true PL2170359T3 (pl) | 2016-11-30 |
Family
ID=39271450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08786472.4T PL2170359T3 (pl) | 2007-07-25 | 2008-07-25 | Zastosowanie otoczek drożdży do leczenia i/lub zapobiegania hiperinsulinemii |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9750762B2 (pl) |
| EP (1) | EP2170359B1 (pl) |
| JP (1) | JP5530354B2 (pl) |
| KR (1) | KR101593705B1 (pl) |
| CN (1) | CN101801400B (pl) |
| AU (1) | AU2008278975B2 (pl) |
| CA (1) | CA2696462C (pl) |
| ES (1) | ES2586244T3 (pl) |
| FR (1) | FR2919187B1 (pl) |
| NO (1) | NO342072B1 (pl) |
| PL (1) | PL2170359T3 (pl) |
| RU (1) | RU2463065C2 (pl) |
| SG (1) | SG169346A1 (pl) |
| SI (1) | SI2170359T1 (pl) |
| WO (1) | WO2009013357A1 (pl) |
| ZA (1) | ZA201000381B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2949064B1 (fr) | 2009-08-14 | 2011-10-07 | Lesaffre & Cie | Nouvelles compositions destinees a la prevention et/ou au traitement du diabete |
| FR2978967B1 (fr) * | 2011-08-09 | 2020-03-20 | Lesaffre Et Compagnie | Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede |
| EP2870969A1 (fr) * | 2013-11-08 | 2015-05-13 | Biocodex | Composition pharmaceutique pour la réduction de la masse adipeuse |
| CN107233298B (zh) * | 2016-03-28 | 2021-01-22 | 复旦大学 | 一种促进蛋白多肽药物口服吸收的酵母细胞壁微粒制剂 |
| WO2019170790A1 (en) * | 2018-03-08 | 2019-09-12 | Dsm Ip Assets B.V. | Yeast beta glucans |
| EP3685681B1 (en) | 2019-01-23 | 2024-07-31 | Lesaffre et Compagnie | A yeast product, and a composition comprising it, for use as a prebiotic agent |
| WO2023175153A1 (en) | 2022-03-18 | 2023-09-21 | Fumi Ingredients B.V. | A microbial cell extract, method for obtaining said microbial cell extract and use of said microbial cell extract |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61167622A (ja) * | 1985-01-22 | 1986-07-29 | Asahi Breweries Ltd | 糖尿病コントロ−ル剤 |
| JP2756907B2 (ja) * | 1993-12-28 | 1998-05-25 | 日本製紙株式会社 | 酵母エキス組成物及びその製造法並びにそれを含有する飼料 |
| FR2800076B1 (fr) * | 1999-10-22 | 2003-11-14 | Lesaffre & Cie | Mannoproteines solubles |
| FR2825004B1 (fr) * | 2001-05-22 | 2005-02-11 | Bio Springer | Produit dietetique satiant |
| EP1663266B1 (fr) * | 2003-08-11 | 2013-02-20 | Lesaffre et Compagnie | Ecorces de levures pour le traitement ou la prevention de l'hyperglycemie ou pour la stabilisation de la glycemie |
| UA85561C2 (ru) * | 2003-08-11 | 2009-02-10 | Лезаффр Э Компани | Применение клеточных стенок дрожжей для лечения или профилактики гипергликемии или для стабилизации содержания сахара в крови |
| JP4302684B2 (ja) * | 2005-06-30 | 2009-07-29 | 株式会社 ミヤトウ野草研究所 | コタラヒンブツ葉エキスを含有した健康食品の製造方法 |
-
2007
- 2007-07-25 FR FR0756731A patent/FR2919187B1/fr active Active
-
2008
- 2008-07-25 CN CN2008801002666A patent/CN101801400B/zh active Active
- 2008-07-25 KR KR1020107004078A patent/KR101593705B1/ko not_active Expired - Fee Related
- 2008-07-25 EP EP08786472.4A patent/EP2170359B1/fr active Active
- 2008-07-25 CA CA2696462A patent/CA2696462C/fr active Active
- 2008-07-25 ES ES08786472.4T patent/ES2586244T3/es active Active
- 2008-07-25 PL PL08786472.4T patent/PL2170359T3/pl unknown
- 2008-07-25 AU AU2008278975A patent/AU2008278975B2/en not_active Ceased
- 2008-07-25 WO PCT/EP2008/059815 patent/WO2009013357A1/fr not_active Ceased
- 2008-07-25 US US12/670,436 patent/US9750762B2/en active Active
- 2008-07-25 SG SG201100526-1A patent/SG169346A1/en unknown
- 2008-07-25 RU RU2010104981/15A patent/RU2463065C2/ru not_active IP Right Cessation
- 2008-07-25 JP JP2010517414A patent/JP5530354B2/ja not_active Expired - Fee Related
- 2008-07-25 SI SI200831660A patent/SI2170359T1/sl unknown
-
2010
- 2010-01-19 ZA ZA201000381A patent/ZA201000381B/xx unknown
- 2010-02-23 NO NO20100268A patent/NO342072B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20100268L (no) | 2010-02-23 |
| RU2010104981A (ru) | 2011-08-27 |
| WO2009013357A1 (fr) | 2009-01-29 |
| JP2010534223A (ja) | 2010-11-04 |
| SI2170359T1 (sl) | 2016-10-28 |
| CN101801400A (zh) | 2010-08-11 |
| CN101801400B (zh) | 2013-10-16 |
| FR2919187A1 (fr) | 2009-01-30 |
| RU2463065C2 (ru) | 2012-10-10 |
| CA2696462C (fr) | 2016-08-23 |
| FR2919187B1 (fr) | 2009-11-27 |
| EP2170359B1 (fr) | 2016-05-11 |
| KR20100063039A (ko) | 2010-06-10 |
| SG169346A1 (en) | 2011-03-30 |
| NO342072B1 (no) | 2018-03-19 |
| JP5530354B2 (ja) | 2014-06-25 |
| EP2170359A1 (fr) | 2010-04-07 |
| AU2008278975B2 (en) | 2013-09-19 |
| CA2696462A1 (fr) | 2009-01-29 |
| ES2586244T3 (es) | 2016-10-13 |
| US9750762B2 (en) | 2017-09-05 |
| US20100196413A1 (en) | 2010-08-05 |
| KR101593705B1 (ko) | 2016-02-12 |
| AU2008278975A1 (en) | 2009-01-29 |
| ZA201000381B (en) | 2010-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL202015A0 (en) | Methods and compositions for treating skin conditions | |
| EP2653873B8 (en) | Compositions and uses for treating Multiple Sclerosis | |
| IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
| IL209895A (en) | Compounds for the prevention and / or treatment of β-amyloidoses | |
| IL232956B (en) | Treatment and prevention of Edosis | |
| IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
| EP2271218A4 (en) | USE AND COMPOSITION FOR THE TREATMENT OF DEMENTIA | |
| PL2340042T3 (pl) | Sposoby i kompozycje do leczenia raka | |
| AU2007208223A8 (en) | Methods and compositions for treating schizophrenia | |
| IL196843A0 (en) | Compositions and methods for the treatment of radiation proctosigmoitis | |
| EP2176406A4 (en) | COMPOSITIONS AND METHOD FOR CANCER TREATMENT | |
| SI2170359T1 (sl) | Uporaba kvasnih kosmičev pri zdravljenju in/ali preprečevanju hiperinzulinemije | |
| WO2007081751A9 (en) | Compositions and methods for the treatment of cancer | |
| GB0718918D0 (en) | Compositions and methods for treating skin conditions | |
| ZA200906782B (en) | Methods of activating IRS-1 and AKT | |
| EP2291284A4 (en) | COMPOSITIONS FOR TREATING MATERIALS AND TREATMENT METHOD THEREFOR | |
| ZA201004894B (en) | Nuctraceutical composition and methods of use | |
| ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
| ZA201000483B (en) | Substances for the protection of cells and/or tissues | |
| WO2009158447A9 (en) | Materials and methods for suppressing and/or treating neurofibroma and related tumors | |
| ZA200901009B (en) | Aza-benzothiophenyl compounds and methods of use | |
| ZA201004893B (en) | Nuctraceutical composition and methods of use | |
| GB0714500D0 (en) | composition and treatment | |
| GB0808326D0 (en) | Compositions and methods for the treatment of fybromyalgia | |
| AU2007900455A0 (en) | Compounds and Methods of Treatment |